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terhadap Aspergillus fumigatus)
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Six pyrano[2,3-c]pyrazole-3-carboxylate and quinoline derivatives (ACP 1A, ACP 1B, ACP 1C, ACP 1D, ACP 2A and 
ACP 4A) synthesized and screened for antimicrobial activity against two selected Gram-positive bacteria (Staphylococcus 
aureus and Bacillus subtilis), three Gram-negative bacteria (Klebsiella pneumonia, Pseudomonas aeruginosa, and 
Escherichia coli), two yeast strains (Candida albicans and Candida glabrata) and two filamentous fungi (Aspergillus 
niger and Aspergillus fumigatus) using agar well diffusion method. Minimum inhibitory concentration (MIC) and 
minimum bactericidal/fungicidal concentration (MBC/MFC) of the compounds were determined using broth microdilution 
and streak plate method, respectively. Time-kill assay (TKA) analysis of N-(2-bromoethyl)-7-chloroquinilin-4-amine 
(ACP 4A) was subsequently conducted throughout the 24 h incubation period against A. fumigatus. Only ACP 4A was 
chosen for the evaluation of TKA analysis because the broth dilution assay confirmed that it is the most potent compound 
with antifungal activity. E. coli was the only one found to be susceptible to the ACP 4A compound at 20 and 30 mg 
mL-1 with an inhibition zone value of 15.00 ± 0.00 and 19.00 ± 0.00 mm, respectively. MIC values of ACP 4A compound 
against S. aureus and C. albicans were 800 µg mL-1. A. niger and A. fumigatus exhibited the highest susceptibility 
towards ACP 4A with the same MIC value (200 µg mL-1).  ACP 4A showed fungicidal effect against C. glabrata with the 
same MIC and MFC values at 800 µg mL-1. From TKA analysis, ACP 4A at 1 × MIC and 2 × MIC did not show fungicidal 
activity against A. fumigatus. In conclusion, ACP 4A has the potential to be developed as a fungistatic (non-fungicidal) 
antifungal agent, which is an advantage compared to other known fungicidal compounds, particularly in patients with 
a healthy immune system. 
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ABSTRAK
Enam terbitan kumpulan pirano[2,3-c]pirazola-3-karboksil dan kuinolina (ACP 1A, ACP 1B, ACP 1C, ACP 1D, ACP 
2A, dan ACP 4A) telah disaring untuk aktiviti antimikrob ke atas dua bakteria Gram positif (Staphylococcus aureus 
dan Bacillus subtilis), tiga bakteria Gram negatif (Klebsiella pneumoniae, Pseudomonas aeruginosa dan Escherichia 
coli), dua strain yis (Candida albicans dan Candida glabrata) dan dua spesies fungus berfilamen (Aspergillus niger 
dan Aspergillus fumigatus) menggunakan kaedah resapan telaga. Nilai kepekatan perencatan minimum (MIC) 
dan kepekatan bakterisid/fungisid minimum (MBC/MFC) sebatian ditentukan menggunakan kaedah mikropencairan 
kaldu dan teknik coretan plat. Asai masa kematian (TKA) sepanjang tempoh inkubasi selama 24 jam untuk sebatian 
N-(2-Bromoetil)-7-klorokuinilin-4-amina (ACP 4A) ditentukan ke atas A. fumigatus. Hanya E. coli sahaja didapati 
rentan terhadap sebatian ACP 4A pada 20 dan 30 mg mL-1 dengan nilai zon perencatan masing-masing, 15.00 ± 0.00 
dan 19.00 ± 0.00 mm. Nilai MIC sebatian ACP 4A terhadap S. aureus dan C. albicans adalah 800 µg mL-1. A. niger dan 
A. fumigatus menunjukkan kerentanan yang paling tinggi terhadap sebatian ACP 4A dengan nilai MIC yang sama (200 
µg mL-1). Sebatian ACP 4A menunjukkan kesan fungisid ke atas C. glabrata dengan nilai MIC dan MFC yang sama iaitu 
800 µg mL-1. Daripada analisis TKA, ACP 4A pada 1 × MIC dan 2 × MIC tidak menunjukkan aktiviti fungisid terhadap 
A. fumigatus. Kesimpulannya, sebatian ACP 4A berpotensi untuk dimajukan sebagai agen antikulat fungistatik yang 
merupakan kelebihan berbanding dengan agen fungisid yang lain, terutamanya pada pesakit dengan immunisasi 
yang baik.
Kata kunci: Antimikrob; bakteria; kuinolina; kulat; pirano[2,3-c]pirazola-3-karboksil
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INTRODUCTION
Infection of bacteria and yeast can occur through direct 
or indirect contact with the infected patients or due to 
opportunistic infection. Bacteria that are commonly 
isolated from the clinical setting are Staphylococcus sp., 
Streptococcus sp., Klebsiella sp., Pseudomonas sp., and 
Escherichia coli. Meanwhile, yeast (Candida sp.) and 
filamentous fungi (Aspergillus sp.) are often the cause 
for severe and life-threatening infections, especially in 
those with immunocompromised state of conditions. 
Examples of antibiotic drug classes often used in the 
clinical setting include glycopeptide, aminoglycoside, 
tetracycline, macrolide penicillin, cephalosporin, and 
fluoroquinolone. However, the increase of antibiotic 
synthesis has also caused problems such as toxicity side 
effects in consumers. Examples of antifungal agent groups 
are polyenes, pyrimidine, and azole. Amphotericin B 
is one of the drugs under the polyene group, but it can 
lead to nephrotoxicity (Joly et al. 1992). Therefore, the 
discovery of alternative drugs in treating bacterial and 
fungal infections is necessary. 
Synthesis of pyrano[2,3-c]pyrazole-3-carboxylate 
derivatives was achieved under green catalysis-free via 
cyclization of four-component reactions comprising 
different carbonyl compound, malononitrile, and hydrazine 
derivatives (Mohammat et al. 2018). Quinoline is a 
heterocyclic aromatic organic compound that consists of a 
benzene ring fused to pyridine at two adjacent carbons. As 
a significant class of pharmaceutically active heterocyclic 
compounds, quinoline and its derivatives demonstrated 
different pharmacological activities such as anticancer 
(Kamath et al. 2016), anticonvulsive (Pawar et al. 2017), 
anti-inflammatory (Upadhyay et al. 2018), antimalarial 
and antiparasitic (Kaur et al. 2010) activities. The in vitro 
antimicrobial activity of four new series of quinoline 
derivatives against Escherichia coli, Staphylococcus 
aureus, Pseudomonas aeruginosa, and Klebsiella 
pneumonia and Mycobacterium tuberculosis were 
demonstrated (Eswaran et al. 2010). The quinoline 
and its derivatives inhibited the growth of S. pyogens, 
S. aureus (Gram-positive), and E. coli, P. aeruginosa 
(Gram-negative), and antifungal activity towards A. niger 
and A. clavatus from disc diffusion assay (Vaghasiya 
et al. 2014). Ambethkar et al. (2015) also showed that 
dihydropyranol[2,3-c]pyrazole derivatives were inhibitory 
by agar well diffusion method against Staphylococcus 
albus, Streptococcus pyogenes, Klebsiella pneumonia, 
Pseudomonas aeruginosa, and Candida albicans. 
Quinoline structures have been identified in several 
synthetic, and natural antifungals due to certain structural 
features producing biological effects more than others. 
The heterocyclic quinoline system comprising carbon 
and nitrogen makes the privileged scaffold recognizable 
within various drug structures with the capability of 
achieving interesting pharmacological properties such as 
an antibiotic, antifungals, antibacterial and antineoplastic 
activities (Constantino & Barlocco 2006). New trends in 
the design of quinolines with antifungal properties, their 
possible targets, and the structure-activity relationship 
proved that it is a valuable scaffold for the rising demand 
for new antifungals drugs (Musiol et al. 2010a).
A simple modification to 8-hydroxyquinoline provides 
an interesting fungicide since the fungistatic activity 
of this compound has been known for many decades. 
Halogenation on the quinoline ring of 8-hydroxyquinoline 
derivatives has been shown improvement on the 
fungitoxicity properties compared to the non-halogenated 
quinoline parent compound (Musiol et al. 2010b). 
Nevertheless, O-functionalized quinolines such as 5-,6- 
and 8-(4-aminobutyloxy) quinolines have also been 
considered as a new class of antifungal agents besides 
their good potency as antimalarial due to the moderate 
cytotoxicity (Vandekerckhove et al. 2013). 
The minimum concentration that inhibits 80 or 50% 
of fungal growth of two clinically important species, C. 
albicans and C. neoformans were tested on quinoline-based 
chalcones compound (Ramírez-Prada et al. 2017). It was 
apparent that C. neoformans were more sensitive than C. 
albicans with low MIC50 and MIC80 of 7.8 µg mL
-1 since 
most of the clinically used antifungals are active at a MIC 
level ≤ 10 µg mL-1.
On the other hand, quinoline derivatives bearing 
pyrazole moiety showed fourfold potency of amphotericin 
B in inhibiting the growth of A. clavatus (MIC 0.49 µg 
mL-1) and C. albicans (MIC 0.12 µg mL-1), respectively. 
The same compound also showed twofold potency 
against the same reference drugs in inhibiting the growth 
of A. fumigatus (MIC 0.98 µg mL-1), thus suggesting 
this attractive scaffold for the development of possible 
antifungal agents (El Shehry et al. 2018). 
As such, quinoline derivatives can be regarded as 
a promising lead in synthesizing novel antimicrobial 
agents.  Therefore, the antimicrobial activity of the six 
newly synthesized pyrano[2,3-c]pyrazole-3-carboxylate 
and quinoline compounds, as shown in Table 1, were 
assessed against selected bacteria and fungi in the hope of 
developing an alternative antimicrobial agent to treat the 
bacterial and fungal infection with minimal side effects. 
MATERIALS AND METHODS
GENERAL PROCEDURE FOR THE SYNTHESIS OF 
PYRANO[2,3-C]PYRAZOLE -3-CARBOXYLATE (ACP 1A- 
ACP1D)
To a solution of diethylaxaloacetate sodium salt (5.5 
mmol) in 10 mL ethanol was added 35% hydrazine solution 
(5.5 mmol) and 1 mL of acetic acid and refluxed for 15 
min. Carbonyl compound (5 mmol) and malononitrile (5 
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mmol) added to the reaction mixture, and heating continued 
for an additional 15 min. The reaction was left to cool, and 
the resulting solid was filtered off and washed with water 
to furnish the pure product.
SYNTHESIS OF ETHYL 6-AMINO-5-CYANO-4-PHENYL-1,4-
DIHYDROPYRANO[2,3-C]PYRAZOLE-3-CARBOXYLATE 
(ACP1A)
The procedure, as mentioned, was followed. ACP 1A 
was isolated as a colorless solid (55%). m.p 224-225 ºC 
(Reported: 226-227 ºC); δH (400 MHz, DMSO) 7.24 (t, J = 
7.3 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 7.05 (t, J = 4.3 Hz, 
2H), 6.99 (s, 2H), 4.70 (s, 1H), 4.04 (q, J = 7.3 Hz, 2H), 
1.00 (t, J = 7.1 Hz, 3H); 13C (100 MHz, DMSO): 160.5 
(CNH2), 158.7 (C=O), 156.1 (CNH), 142.4 (quat. Ar C), 
129.6 (C=N), 128.8 (Ar C), 127.9 (Ar C), 127.1 (Ar C), 
120.8 (CN), 104.1 (quat. C), 61.3 (CH2), 58.4 (quat. C), 
37.5 (CH), 14.3 (CH3).  Anal. calc. for C16H14N4O3, C 61.93, 
H 4.55, N 18.06. Found: C 62.04, H 4.52, N 20.83.
SYNTHESIS OF ETHYL 6-AMINO-5-CYANO-4-(4-
ETHYLPHENYL)-1,4-DIHYDROPYRANO[2,3-C]PYRAZOLE-3-
CARBOXYLATE (ACP1B)
The procedure mentioned before was repeated, and ACP 
1B was isolated as yellowish solid (50%); m.p 212-213 
ºC (Reported: 212-213 ºC); δH (400 MHz, DMSO) 7.07 (d, 
J = 8.2 Hz, 2H), 6.96 (s, 2H), 6.95 (d, J = 7.6 Hz, 2H), 
4.67 (s, 1H), 4.07 (q, J = 7.0 Hz, 2H), 2.52 (q, J = 7.5 Hz, 
2H), 1.10 (t, J = 7.5 Hz, 3H), 1.01 (t, J = 7.1 Hz, 3H); 13C 
(100 MHz, DMSO): 160.5 (CNH2), 158.7 (C=O), 156.1 
(CNH), 145.5 (quat. Ar C), 129.6 (C=N), 128.8 (Ar C), 
127.9 (Ar C), 127.1 (Ar C), 120.8 (CN), 104.1 (quat. C), 
61.3 (CH2), 58.4 (quat. C), 37.5 (CH), 14.3 (CH3); Anal. 
calc. for C18H18N4O3, C 63.89, H 5.36, N 16.56. Found: C 
64.46, H 5.41, N 18.71.
SYNTHESIS OF ETHYL 6-AMINO-5-CYANO-4-(FURAN-2-YL)-
1,4-DIHYDROPYRANO[2,3-C]PYRAZOLE-3-CARBOXYLATE 
(ACP1C)
The procedure, as mentioned before, was followed. ACP 
1C was isolated as yellowish solid (61%); m.p 217-218 
ºC (Reported: 216-218 ºC); δH (400 MHz, DMSO): 7.44 
(d, J = 2.7 Hz, 1H), 7.08 (s, 2H), 6.31 (dd, J = 3.2 Hz, 1.8 
Hz, 1H), 6.07 (d, J = 2.7 Hz, 1H), 4.88 (s, 1H), 4.14 (q, 
J= 6.2 Hz, 2H), 1.13 (t, J = 7.1 Hz, 3H); 13C (100 MHz, 
DMSO): 161.3 (CNH2), 158.8 (C=O), 156.2 (CNH), 156.0 
(quat. C.), 142.4 (CH), 129.6 (quat C.) 120.7 (CN), 110.9 
(CH), 106.0 (CH), 101.5 (quat. C), 61.5 (CH2), 55.3 (quat. 
C), 31.2 (CH), 14.4 (CH3); Anal. calc. for C14H12N4O4, C 
56.00, H 4.03, N 18.66. Found: C 56.29, H 4.04, N 21.32.
SYNTHESIS OF ETHYL 6-AMINO-5-CYANO-4-ISOPROPYL-
1,4-DIHYDROPYRANO[2,3-C]PYRAZOLE-3-CARBOXYLATE 
(ACP1D)
The procedure mentioned before was followed. ACP 1D 
was isolated as a colorless solid (57%); m.p: 189-190 ℃ 
(Reported: 200-201 ℃); δH (400 MHz, DMSO): 6.97 (s, 
2H), 4.40-4.09 (dt, J=6.8, 3.6 Hz, 2H), 3.58 (d, J = 2.7 Hz, 
1H), 2.12-1.85 (m, 1H), 1.28 (t, J = 7.1 Hz, 3H), 0.94 (d, 
J = 6.9 Hz, 3H), 0.57 (d, J = 6.9 Hz, 3H); RMN 13C (100 
MHz, DMSO): 163.5 (CNH2), 159.2 (C=O), 157.0 (CNH), 
128.7 (quat. C), 122.3 (CN), 105.3 (quat. C), 61.5 (CH2), 
51.8 (quat. C), 37.6 (CH), 35.7 (CH), 20.7 (CH3), 17.2 (CH3), 
14.5 (CH3); Anal. calc. for C13H16N4O3, C 56.51, H 5.84, N 
20.28. Found: C 56.18, H 5.85, N 21.93.
SYNTHESIS OF COMPOUND 2-((7-CHLOROQUINOLIN-4-YL)
AMINO)ETHAN-1-OL (ACP2A) 
A mixture solution of 4,7-dichloroquinoline (0.99 g, 5 
mmol) and 2-aminoethanol (1.5 mL, 25 mmol) was heated 
at 120-130 °C for 3 h under nitrogen atmosphere. Upon 
completion, reaction mixture was transferred into ice 
cold water and stirred at 0 °C for an hour. The resulting 
precipitate was filtered, washed repeatedly with cold water 
three times and dried in a vacuum oven at 70 °C to yield a 
colorless solid with 93% yield. M.p 210-211 °C; δH (400 
MHz, DMSO): 8.34 (d, J = 5.0 Hz, 1H), 8.21 (d, J = 8.7 
Hz, 1H), 7.74 (d, J = 2.3 Hz, 1H), 7.40 (dd, J = 9.1, 2.3 
Hz, 1H), 7.24 (t, J = 5.5 Hz, 1H), 6.46 (d, J = 5.5 Hz, 1H), 
4.81 (t, J = 5.5 Hz, 1H), 3.62 (q, J = 5.8 Hz, 2H), 3.30 (q, 
J = 5.8 Hz, 2H); 13C (100 MHz, DMSO) δ 152.418 (Ar C), 
150.8 (quat. C), 149.6 (quat. C), 133.9 (quat. C), 128.0 (Ar 
C), 124.6 (Ar C), 124.5 (Ar C), 118.0 (quat. C), 99.2 (Ar 
C), 59.3 (CH2Br), 45.6 (CH2N).
SYNTHESIS OF N-(2-BROMOETHYL)-7-CHLOROQUINOLIN-4-
AMINE (ACP4A)
Compound ACP2A dissolved in aq. HBr (33%) solution 
at 0 ℃ and conc. H2SO4 added dropwise, maintaining the 
temperature at room temperature for 15 min. The reaction 
mixture heated at 160 °C for 3 h. Subsequently, the reaction 
mixture transferred into ice-cold water, and ammonium 
hydroxide was added dropwise until pH 9. The resulting 
precipitate was filtered and added into a solution of 
toluene containing charcoal. The mixture was kept in the 
fridge at 4 ℃ to obtain a colorless solid (40%); m.p 140-
141 ℃; δ H (400 MHz, DMSO): 8.36 (d, J = 5.5 Hz, 1H), 
8.06 (d, J = 9.1 Hz, 1H), 7.77 (d, J = 2.3 Hz, 1H), 7.40 
(dd, J = 8.7, 2.3 Hz, 1H), 6.56 (d, J = 5.5 Hz, 1H), 3.79 (t, 
J = 6.6 Hz, 2H), 3.64 (t, J = 6.4 Hz, 2H); 13C (100 MHz, 
CD3OH): δ 151.1 (Ar C), 150.9 (quat. C), 148.3 (quat. C), 
135.2 (quat. C), 126.3 (Ar C), 125.0 (Ar C), 122.9 (Ar C), 
117.4 (quat. C), 98.4 (Ar C), 44.2 (CH2Br), 29.0 (CH2N).
PREPARATION OF STOCK SOLUTION OF HETEROCYCLIC 
ORGANIC COMPOUNDS
Pyrano[2,3-c]pyrazole-3-carboxylate and quinoline 
derivatives (ACP 1A, ACP 1B, ACP 1C, ACP 1D, ACP 
2A and ACP 4A) synthesized and characterized by the 
Department of Chemical Sciences, Faculty of Science 
and Technology. The molecular structure of these 
heterocyclic organic compounds was shown in Table 
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1. Pyrano[2,3-c]pyrazole-3-carboxylate and quinoline 
compound at 40,000 µg mL-1 solution was prepared by 
solubilizing 0.4 g of these heterocyclic organic compounds 
powder into 10 mL DMSO. The stock solution mixed using 
vortex for 5 min. The stock solution stored at -20 ℃ until 
further use.
TABLE 1. Six heterocyclic organic compounds containing pyrano[2,3-c]pyrazole-3-carboxylate and quinoline moieties






























PREPARATION OF TEST MICROORGANISMS 
Two Gram-positive bacteria (Staphylococcus aureus ATCC 
25923 and Bacillus subtilis), three Gram-negative bacteria 
(Escherichia coli ATCC 25922, Klebsiella pneumonia, and 
TABLE 1. Six heterocyclic organic compounds containing pyrano[2,3-c]pyrazole-3-
carboxylate and quinoline moieties 
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Pseudomonas aeruginosa ATCC 27853), two yeast strains 
(Candida albicans ATCC 900028 and Candida glabrata 
ATCC 64677) and two filamentous fungi (Aspergillus 
niger ATCC 6275 and Aspergillus fumigatus ATCC 
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204305) were obtained from the Laboratory Collection 
Centre, Faculty of Health Sciences, Universiti Kebangsaan 
Malaysia, Kuala Lumpur (UKM KL). Bacteria and fungi 
were cultured on nutrient agar (NA) and potato dextrose 
agar (PDA), respectively, at Infectious Disease Laboratory, 
Faculty of Health Sciences, UKM KL. Bacteria and yeast 
incubated in 37 ℃ overnight, while filamentous fungi 
incubated at a lower temperature of 30 ℃ for 3 to 4 days. 
The seeding of filamentous fungi was prepared by adding 
2 mL sterile 0.85% NaCl and scraped off using a pipette 
tip followed by filtration through a double layer sterile 
gauze to remove large hyphae fragments for culture done 
by plug inoculation. The standardized inoculum size of 
all microorganisms were achieved by adjusting the optical 
density of bacteria and yeast suspension, respectively, 
at turbidity corresponding to an absorbance (A) reading 
at 0.08 at 625 nm and 0.11 to 0.14 at 530 nm which is 
equivalent to an estimated concentration of 108 CFU mL-1 
for bacteria and 106 CFU mL-1 for yeast, respectively. As 
for filamentous fungi, the inoculum size was standardized 
to absorbance (A) reading within the range of 0.09 to 0.11 
at 530 nm which corresponded to a range of 1.0 × 106- 5.0 
× 106 spores mL-1.
DETERMINATION OF ANTIMICROBIAL ACTIVITY USING 
AGAR WELL DIFFUSION ASSAY
Six heterocyclic organic compounds were used for 
antibacterial and antifungal screening tests using the 
agar well diffusion method. Mueller-Hinton agar (MHA) 
uniformly seeded with test bacteria by spreading the 
inoculum on the surface of the agar plate with a sterile 
swab. On the other hand, PDA was applied as the seed 
medium for yeast and filamentous fungi. The agar wells 
(8 mm diameter) were punched and placed with the test 
compounds (50 µL) at concentration 10, 20, and 30 mg 
mL-1. For positive control, gentamicin (10 µg mL-1) was 
used for bacteria, whereas amphotericin B (20 µg mL-1) 
was applied for yeast and filamentous fungi. For negative 
control, 5% DMSO was used for bacteria, whereas distilled 
water was used for yeast and filamentous fungi. The 
bacteria and yeast plates were incubated at 37 ℃ for 24 
h, whereas filamentous fungi plates were incubated at 30 
℃ for 36 h. The test was done in duplicates to ensure the 
reliability of the compound assayed. The antimicrobial 
activity was performed by measuring the diameter of the 
zone of inhibition in mm.  
DETERMINATION OF MINIMUM INHIBITORY 
CONCENTRATION (MIC) AND MINIMUM BACTERICIDAL/
FUNGICIDAL CONCENTRATION (MBC/MFC) ASSAY
The MIC value of each compound can be identified by 
using a two-fold serial microdilution method in 96 well 
microtiter plates. Initially, 100 µL of test compound 
at concentration 3200 µg mL-1 was added to 100 µL 
sterile broth media. Subsequently, 100 µL of diluted 
microorganism suspension with the final inoculum of 
106 CFU mL-1 (bacteria) and 104 CFU mL-1 (yeast and 
filamentous fungi) were combined into the 96 well plates. 
The microdilution fixed at a final compound concentration 
ranging from 25 to 800 µg mL-1. Each compound tested 
in triplicates. The compound in the broth was used as a 
negative control to ensure the sterility of medium.
Meanwhile, the microorganism suspensions served 
as a positive control to make sure the growth of the 
microorganism in the broth. The lowest concentration to 
inhibit the growth of microorganisms determined as MIC 
value. The MBC value was analyzed by sub-culturing the 
well with the lowest concentration displayed no-growth 
of microorganisms on a sterile agar plate.
DETERMINATION OF RATE-KILLING ACTIVITY USING TIME-
KILL ANALYSIS (TKA) ASSAY
The time-kill curves of the compound evaluated using the 
broth microdilution assay. Initially, 10 mL suspension of 
fungus inoculum prepared using RPMI-1640 broth. The 
volume of fungus inoculum removed is the same as the 
volume of the compound added into the suspension to get 
1 × MIC and 2 × MIC concentration of the compound. The 
growth control tube comprised only microorganisms and 
RPMI-1640 broth. The tubes were later incubated at 30 ℃, 
and viable count performed at 0, 2, 4, 6, 8, and 24 h. At 
each hour, 0.1 mL of the sample removed from the tube 
was diluted ten-fold with 0.9 mL of 0.9% normal saline 
and spread on PDA plates using an L-shaped rod and 
incubated for 18 h at 30 ℃. The colony count of fungus 
for each plate was determined to obtain time-mortality 
curves by plotting the log10 CFU mL
-1 on the y-axis and time 
on the x-axis. The fungicidal effect depicted if there was 
a decrease of ≥ 3 log10 CFU mL
-1 in colony counts within 
24 h while the fungistatic effect described if there was ≤ 
3 log10 CFU mL
-1 reduction in colony counts within 24 h.
RESULTS
  
DETERMINATION OF INHIBITION ZONE
The diameter of the inhibition zone of the compounds 
against five bacterial strains and four fungal species were 
shown in Tables 2 and 3, respectively. Based on the results 
obtained, only the ACP 4A showed the antimicrobial 
activity with the formation of an inhibition zone. Compared 
to Gentamicin (10 µg mL-1) which produced inhibition 
zone of 17.0 ± 0.00 mm against E. coli, ACP 4A was 
only capable of inhibiting the growth of E. coli at 20 and 
30 mg mL-1, with an inhibition zone of 15.0 ± 0.00 and 
19.0 ± 0.00 mm, respectively. In other words, among all 
the tested bacteria and fungi, only Escherichia coli was 
susceptible to ACP 4A. All the tested compounds were 
not able to inhibit the growth of S. aureus, B. subtilis, K. 
pneumoniae, P. aeruginosa, C. albicans, C. glabrata, A. 
niger, and A. fumigatus.
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TABLE 2. Mean diameter of inhibition zones of six heterocyclic organic compounds against five tested bacteria
Tested bacteria Heterocycliccompounds 
The diameter of inhibition zones 
(mean ± SD)
Concentration of compounds (mg 
mL-1)





ACP 1A - - - 16.0 ± 0.00 -
ACP 1B - - - 16.0 ± 0.00 -
ACP 1C - - - 16.0 ± 0.00 -
ACP 1D - - - 16.0 ± 0.00 -
ACP 2A - - - 16.0 ± 0.00 -
ACP 4A - - - 16.0 ± 0.00 -
Bacillus subtilis
ACP 1A - - - 20.67 ± 0.52 -
ACP 1B - - - 20.67 ± 0.52 -
ACP 1C - - - 20.67 ± 0.52 -
ACP 1D - - - 20.67 ± 0.52 -
ACP 2A - - - 20.67 ± 0.52 -
ACP 4A - - - 20.67 ± 0.52 -
Escherichia coli
ACP 1A - - - 17.0 ± 0.00 -
ACP 1B - - - 17.0 ± 0.00 -
ACP 1C - - - 17.0 ± 0.00 -
ACP 1D - - - 17.0 ± 0.00 -
ACP 2A - - - 17.0 ± 0.00 -
ACP 4A - 15.0 ± 0.00 19.0 ± 0.00 17.0 ± 0.00 -
Klebsiella pnemoniae
ACP 1A - - - 17.0 ± 0.00 -
ACP 1B - - - 17.0 ± 0.00 -
ACP 1C - - - 17.0 ± 0.00 -
ACP 1D - - - 17.0 ± 0.00 -
ACP 2A - - - 17.0 ± 0.00 -
ACP 4A - - - 17.0 ± 0.00 -
Pseudomonas 
aeruginosa
ACP 1A - - - 15.0 ± 0.00 -
ACP 1B - - - 15.0 ± 0.00 -
ACP 1C - - - 15.0 ± 0.00 -
ACP 1D - - - 15.0 ± 0.00 -
ACP 2A - - - 15.0 ± 0.00 -
ACP 4A - - - 15.0 ± 0.00 -
Note:
 -    : No inhibition zone
Positive control  : Gentamicin 10 µg mL-1
Negative control  : 5% DMSO
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TABLE 3. Mean diameter of inhibition zones of six heterocyclic organic compounds against four tested fungi
Tested fungi Heterocyclic compounds
The diameter of inhibition zones 
(mean ± SD)
Concentration of compounds (mg 
mL-1)




ACP 1A - - - 29.0 ± 0.00 -
ACP 1B - - - 29.0 ± 0.00 -
ACP 1C - - - 29.0 ± 0.00 -
ACP 1D - - - 29.0 ± 0.00 -
ACP 2A - - - 29.0 ± 0.00 -
ACP 4A - - - 29.0 ± 0.00 -
Candida glabrata
ACP 1A - - - 34.0 ± 0.00 -
ACP 1B - - - 34.0 ± 0.00 -
ACP 1C - - - 34.0 ± 0.00 -
ACP 1D - - - 34.0 ± 0.00 -
ACP 2A - - - 34.0 ± 0.00 -
ACP 4A - - - 34.0 ± 0.00 -
Aspergillus niger
ACP 1A - - - 23.7 ± 1.51 -
ACP 1B - - - 23.7 ± 1.51 -
ACP 1C - - - 23.7 ± 1.51 -
ACP 1D - - - 23.7 ± 1.51 -
ACP 2A - - - 23.7 ± 1.51 -
ACP 4A - - - 23.7 ± 1.51 -
Aspergillus 
fumigatus
ACP 1A - - - 18.0 ± 0.00 -
ACP 1B - - - 18.0 ± 0.00 -
ACP 1C - - - 18.0 ± 0.00 -
ACP 1D - - - 18.0 ± 0.00 -
ACP 2A - - - 18.0 ± 0.00 -
ACP 4A - - - 18.0 ± 0.00 -
Note:
 -                        :          No inhibition zone
Positive control :          Amphotericin 20 µg mL-1
Negative control:         Distilled water
DETERMINATION OF MIC AND MBC/MFC
Tables 4 and 5 showed the result of the broth microdilution 
method of the compounds against nine microorganisms 
tested. As seen in Table 4, only S. aureus was susceptible 
to ACP 4A out of a total of five bacterial species screened. 
The MIC value of ACP 4A was 800 µg mL-1 compared to the 
MIC value of Gentamicin at a range of 0.125 to 8 µg mL-1 
against S. aureus. ACP 4A, however, exhibited antifungal 
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activity against all the four fungal species tested, namely, 
C. albicans, C. glabrata, A. niger, and A. fumigatus (Table 
5). The lowest MIC values obtained for the ACP 4A was 
against A. niger and A. fumigatus, which was 200 µg 
mL-1. This value showed that A. niger and A. fumigatus 
were more susceptible to ACP 4A compared to both the 
Candidal strains. Similar to S. aureus, both C. glabrata 
and C. albicans also showed the same MIC value of 800 
µg mL-1 by ACP4A. However, the MBC/MFC value of ACP 
4A against S. aureus and C. albicans was higher than 800 
µg mL-1, whereas the MFC value of ACP 4A against C. 
glabrata was 800 µg mL-1. In other words, the MIC and 
MBC values of the ACP 4A against C. glabrata were the 
same, which was 800 µg mL-1. The MFC values of ACP 4A 
against A. niger and A. fumigatus appeared to be higher 
than 800 µg mL-1 and cannot be determined as the test 
concentration was from 25 to 800 µg mL-1.
TABLE 4. MIC and MBC values for six heterocyclic organic compounds against tested bacteria









ACP 1A > 800 ND
0.125 (MIC)
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A 800 > 800
Bacillus subtilis
ACP 1A > 800 ND
0.25 (MIC)
 8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A > 800 ND
Escherichia coli
ACP 1A > 800 ND
0.25 (MIC) 
 8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A > 800 ND
Klebsiella 
pnemoniae
ACP 1A > 800 ND
0.50 (MIC)
 8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A > 800 ND
Pseudomonas 
aeruginosa
ACP 1A > 800 ND
0.125 (MIC) 
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A > 800 ND
Note:
ND   : Not determined
Positive Control : Gentamicin 32 µg mL-1
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MIC              (µg 
mL-1)
MBC/MFC         (µg 
mL-1)
Positive control (µg 
mL-1)
Candida albicans
ACP 1A > 800 ND
0.25 (MIC)
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A    800 > 800
Candida glabrata
ACP 1A > 800 ND
0.25 (MIC)
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A    800 800
Aspergillus niger
ACP 1A > 800 ND
2.00 (MIC)
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A    200 > 800
Aspergillus 
fumigatus
ACP 1A > 800 ND
4.00 (MIC)
8.00 (MBC)
ACP 1B > 800 ND
ACP 1C > 800 ND
ACP 1D > 800 ND
ACP 2A > 800 ND
ACP 4A    200 > 800
Note:
ND: Not determined
Positive Control: Amphotericin B 32 µg mL-1
DETERMINATION OF TKA ANALYSIS
As seen from Figure 1, the ACP 4A compound at 1 × MIC 
and 2 × MIC concentration did not show the fungicidal 
effect against A. fumigatus throughout the 24 h incubation 
period. The plot of time-kill assay illustrated no reduction 
of colony count of more than 3 log10 CFU mL
-1 by ACP 4A 




Life-threatening pathogenic microorganisms infection 
is on the rise and becoming the leading cause of death 
worldwide (Stein 2011). Toxic effects from the current 
use of antimicrobial agents have limited the selection of 
drugs in treating the diseases (Mandhane et al. 2015). 
Therefore, novel heterocyclic organic compounds such 
as ACP 1A, ACP 1B, ACP 1C, ACP 1D, ACP 2A, and ACP 
4A were assessed for their antimicrobial activity against 
five bacteria and four fungi species. 
From the agar well diffusion assay, only ACP 4A 
showed antimicrobial activity, and the rest of the novel 
heterocyclic organic compounds was not capable of 
inhibiting the growth of all nine tested microorganisms. 
Among all the tested bacteria and fungi, only Escherichia 
coli was susceptible to ACP 4A despite being 2000-3000 
times less potent than gentamicin as an antimicrobial 
agent against E. coli. For pure compound, this cannot be 
considered an important finding as the potency of ACP 4A 
would ideally be better or close to the positive control.
The identification and characterization of the effect 
of compounds against the tested microorganisms by 
comparing the MIC and MBC values of each compound are 
also crucial. From the broth microdilution assay, it was 
shown that MBC values of ACP 4A against S. aureus, C. 
albicans, A. niger, and A. fumigatus were higher than their 
MIC values. As such, it can be interpreted that ACP 4A 
displayed bacteriostatic against S. aureus and fungistatic 
against C. albicans, A. niger, and A. fumigatus. However, 
out of these four susceptible tested microorganisms, ACP 4A 
was equally potent against both A. niger and A. fumigatus 
with the lowest MIC values among all the susceptible 
FIGURE 1. Graph of log (CFU mL-1) against time (hours). Graph 
showing the time-kill curve for A. fumigatus which treated with ACP 4A 
compound, amphotericin B and growth control
tested microorganisms. This observation indicated that 
as a fungistatic agent, ACP 4A was more effective in 
combating the filamentous fungi compared to yeast and 
bacteria studied. While for C. glabrata, the MIC and MBC 
values were the same and can be interpreted that the ACP 
4A exhibited a fungicidal effect against C. glabrata. The 
presence of the electron-withdrawing group (Cl) at the para 
position of the quinoline ring and halogen atom, which is 
the bromine in the chemical structure, could be responsible 
for the antimicrobial activity. Aforementioned, it is in 
line with the results obtained by Garudachari et al. (2012) 
and Shakhatreh et al. (2016), which had shown that the 
presence of an electron-withdrawing group could increase 
the antimicrobial activity. The other five heterocyclic 
compounds did not show any inhibition activity against 
tested microorganisms, which is due to the absence of 
halogen atom in their chemical structures. According to 
the study of Bahrin et al. (2016), halogen atoms could 
influence antimicrobial activity. 
However, the study showed a contradictory result 
between agar well diffusion assay and micro broth dilution 
assay. The concentration of compounds applied in 
agar well diffusion assay was higher than in MIC assay. 
Nonetheless, it was still incapable of inhibiting the 
growth of five susceptible microorganisms, as shown 
in the MIC assay. Herein, no linear relationship between 
the size of the inhibition zone and the concentration of 
tested compounds was observed. Moreover, the methods 
employed in these two assays were different. In agar well 
diffusion assay, the solid medium was applied, whereas, 
in the MIC assay, the liquid medium is preferable. Hence, 
the results obtained were different.
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but was fungistatic against C. albicans, A. niger, and A. 
fumigatus. TKA assay confirmed the MIC and MFC results 
that ACP 4A was fungistatic against A. fumigatus. Hence, 
the ACP 4A compound has the potential to be developed as 
an alternative treatment for A. fumigatus infection. 
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